U.S. Halts Use of Celebrex in Cancer Trial
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
315903
A study testing whether naproxen would reduce the risk of Alzheimer's disease was halted after researchers noted an increase in heart attack and stroke among participants who were taking the pain reliever.
273310
An Alzheimer's disease prevention trial was suspended after researchers said there were more heart attacks and strokes among patients taking naproxen, an over-the-counter pain reliever in use for 28 years and commonly known under the brand name Aleve.
418961
The arthritis drug rofecoxib (Vioxx) was withdrawn from the market after a study demonstrated that it increases the risk of heart attack and stroke.
214766
Doctors should limit use of Pfizer Inc.&#39;s Celebrex and Bextra pain drugs while regulators continue to weigh their cardiovascular risks, the US Food and Drug Administration said today.
90172
Merck Labs has pulled Vioxx, their arthritis drug, off the market after discovering during trials the possibility of a link to stroke or heart attack.
203289
Germany's drug regulator on Monday  told patients with cardiovascular risks to stop using Pfizer's  arthritis drug Celebrex after new data emerged linking it to an  elevated risk of heart attacks.
203379
An international trial comparing blood-pressure lowering treatments has been stopped early due to the significantly better performance of one of the treatments in the trial.
333725
Merck &amp; Co. (MRK.N: Quote, Profile, Research) said on Thursday withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke.
252263
Pfizer Inc. on Friday said patients taking its blockbuster arthritis drug Celebrex in a long-term cancer-prevention trial had more than twice the number of fatal or non-fatal heart attacks as those taking a placebo.
336646
US drug giant Pfizer has said a trial had found a sharp rise in heart attacks for patients using its Celebrex arthritis and pain medicine but it would not immediately withdraw the treatment.
423243
The US National Institutes of Health halted an Alzheimer&#39;s prevention study of Pfizer Inc.&#39;s Celebrex painkiller and the generic naproxen drug because of a heart risk.
421848
A trial of Bayer AG's  heart surgery drug Trasylol was halted after an increased risk of death from bleeding was linked to the treatment, the company said on Thursday.
692172
German drug group Bayer said Monday that it had halted trials of its leading cancer treatment Nexavar for one of the main forms of lung cancer.
196813
U.S. health officials on Thursday  called on doctors to limit prescribing Pfizer Inc. painkillers  Celebrex and Bextra in light of recent evidence that they may  increase the risk of heart attack and stroke.
390422
FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting debate on the safety of two popular painkillers.
518038
Pfizer Inc. has agreed to suspend its advertisements for arthritis drug Celebrex while U.S. regulators review new data that link the drug to an elevated risk of heart attacks, a Food and Drug Administration spokeswoman said on Sunday.